| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | Chief Medical Officer | Employee Stock Option (right to buy) | 115,500 | 24 Feb 2022 | Direct | ||
| PhaseBio Pharmaceuticals Inc | Chief Medical Officer | Restricted Stock Unit | 24,750 | 24 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000116924522000011-lee-john-sang-2022-02-24 | PhaseBio Pharmaceuticals Inc | 24 Feb 2022 | 2 | $0 | 4 | Chief Medical Officer | 28 Feb 2022, 18:23 |